Andrx Corporation

Andrx Corporation is a specialty pharmaceutical company that develops, manufactures, and sells branded and generic prescription pharmaceuticals and Active Pharmaceutical Ingredients (APIs). The company's branded pharmaceuticals include: Vasostrict (vasopressin injection, USP), the market-leading injectable vasopressin product, indicated for the acute treatment of bleeding esophageal varices; Zipsor (vancomycin injection, USP), an antibiotic for injection, indicated for the treatment of infections; and Vimovo (naproxen and esomeprazole magnesium), a prescription product indicated for relief of osteoarthritis pain and inflammation. The company's generic pharmaceuticals include a broad range of branded and generic prescription drugs with a focus on: dermatology, where the company's portfolio includes 16 branded products and over 30 ANDAs approved for marketing in the United States; antibiotics and anti-infectives, where the company's portfolio includes 6 branded products, including the Zipsor brand, and over 30 ANDAs approved for marketing in the United States; central nervous system, where the company's portfolio includes approximately 10 branded products and 25 ANDAs approved for marketing in the United States; and cardiovascular, where the company's portfolio includes one branded product and approximately 20 ANDAs approved for marketing in the United States. The company's branded and generic pharmaceuticals are sold to both retail and mail-order pharmacies, hospitals and wholesalers throughout the United States. The company also sells its branded pharmaceuticals directly to the Department of Veterans Affairs through a Federal Supply Schedule contract. The company's manufacturing facilities are located in Davie, Florida, Swiftwater, Pennsylvania, and St. Louis, Missouri. The company's corporate headquarters are located in Davie, Florida.

Drugs and Druggists' Sundries Merchant Wholesalers; Pharmaceutical and Medicine Manufacturing; Drugs and Druggists' Sundries Merchant Wholesalers; Chemical Manufacturing; Manufacturing

Drugs, Proprietaries, and Sundries; Pharmaceutical Preparations; Chemicals and Allied Products; Manufacturing

$459.7M